Právní předpis byl sestaven k datu 09.02.2026.
Zobrazené znění právního předpisu je účinné od 29.12.2023.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2024
420/2023 Sb.
420
SDĚLENÍ
Ministerstva xxxxxxxxxxxxx
xx xxx 19. xxxxxxxx 2023
o xxxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx xxx 2024
&xxxx;
Xxxxxxxxxxxx zdravotnictví podle §80 xxxx. 1 xxxx. e) xxxxxx x. 258/2000 Sb., x ochraně veřejného xxxxxx a x xxxxx některých xxxxxxxxxxxxx xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, xxxxxxx xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx pro xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2024:
1.&xxxx;Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x)&xxxx;xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (acelulární forma), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1&xxxx;xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1&xxxx;xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1&xxxx;25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)1&xxxx;25 xxxxxxxxxx
Xxxxxxxxxxx (XXX)1&xxxx;8 xxxxxxxxxx
Xxxxxxxxx tegiminis xxxxxxxxxxx B (XXx)2,3&xxxx;10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx (XXX)
xx pus 1 (xxxx Mahoney)4 40 X xxxxxxxx antigenu
typus 2 (xxxx MEF-1)4 8 D xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Saukett)4 32 X xxxxxxxx antigenu
Haemophilus influenzae xxxxx b xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 10 mikrogramů
conj. xxx anatox. tetanico xxxx nosný protein xxxxxxxxx 25 xxxxxxxxxx
1&xxxx;xxxxxxxxxxx xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 xxxxxxxxx Xx3+
2&xxxx;xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx xxxxxxxxxx)
3&xxxx;xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (XxXX4) 0,32 xxxxxxxxx Al3+
4 pomnoženo xx XXXX xxxxxxx
XXXX
1xx)&xxxx;xxxxxxxxxxx xxxxxxxx látka proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx B, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX)
Xxxxx xxxxx1&xxxx;(0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx ne xxxx xxx 20 mezinárodních xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx xx méně xxx 40 xxxxxxxxxxxxx jednotek (XX)2
Xxxxxxxx Bordetelly pertussis
Pertussis xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 mikrogramů
Virus Xxxxxxxxxxxxxxx (inaktivovaný)3
typus 1 (Xxxxxxx) 40 X xxxxxxxx antigenu4
ty xxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X jednotek antigenu4
Antigenum xxxxxxxxx xxxxxxxxxxx X5&xxxx;10 xxxxxxxxxx
Xxxxxxxxxxxxxxxxxxx xxxxxxxx haemophili xxxxxxxxxx B 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phosphas)
conjugata xxx xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx
1&xxxx;xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý (0,6 xx Al3+)
2 jako xxxxxx xxx spolehlivosti (p = 0,95)
3&xxxx;xxxxxxxxx na XXXX buňkách
4 nebo xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx
5&xxxx;xxxxxxxx xxxxxxxxxxxxx DNA technologií x kvasinkových xxxxxxx Xxxxxxxxx polymorpha
NEBO
1ab) Vakcína xxxxx xxxxxxx, xxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx), xxxxxxxxxx X (xXXX), xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx) x xxxxxxxxxxx xxxxxxx xxxxx Haemophilus xxxx x (adsorbovaná)
Jedna xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1&xxxx;xx xxxx xxx 20 XX
Xxxxxx xxxxxxxxxx1&xxxx;xx xxxx xxx 40 IU
Antigena Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx xxxxxxxxxx (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 mikrogramů
Pertactinum (XXX) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (FIM) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X&xxxx;2,3&xxxx;10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)4
Xxxxx 1 (Mahoney) 40 X jednotek xxxxxxxx5
Xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 D xxxxxxxx xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx influenzae xxxxx x
(Xxxxxxxxxxxxxxxxxxx phosphas) 3 xxxxxxxxxx xxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxx x2&xxxx;50 xxxxxxxxxx
1&xxxx;xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,17 mg Al3+)
2 adsorbováno xx hydratovaný xxxxxxxx xxxxxxx xxxxxx (0,15 xx Xx3+)
3&xxxx;xxxxxxxx rekombinantní XXX xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx
4&xxxx;xxxxxxxxx na Xxxx xxxxxxx
5&xxxx;xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx stanovené xxxxxxx xxxxxxxxxxxxxx xxxxxxx.
1x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx (DTaP)
Jedna xxxxx (0,5 xx) obsahuje xxxx xxxxxx látky:
Diphtheriae xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx* (XXX) 25 mikrogramů
Pertactinum* (69kD) 8 xxxxxxxxxx
*&xxxx;xxxxxxxxxxx xx xxxxxxxx xxxxxxx xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx)&xxxx;Xxxxxxxx xxxxx xxxxx záškrtu, tetanu x xxxxxxxx kašli (xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Xxxxxxxxx 2 XX* (2 Lf)
Tetani xxxxxxxxxx - Xxxxxxxxx 20 XX* (5 Lf)
Pertusové xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 mikrogramu
Pertactinum - 3 mikrogramy
Fimbriae, xxxx 2 et 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx - 1,5 xx (0,33 mg xxxxxxx)
*&xxxx;Xxxx xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (p = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
XXXX
1xx)&xxxx;Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1&xxxx;xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1&xxxx;xx méně xxx 20 mezinárodních xxxxxxxx (IU) (5 Xx)
Xxxxxxxxxxx pertussis xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1&xxxx;8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1&xxxx;8 mikrogramu
Pertussis membranae xxxxxxxx xxxxxxxxx1&xxxx;2,5 mikrogramu
1 adsorbováno xx xxxxxxxxxxx xxxxxxxx xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Al3+ a fosforečnan xxxxxxx (AIPO4) 0,2 xxxxxxxxx Xx3+
1x)&xxxx;xxxxxxxx xxxxx xxxxx nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x:
Xxxxx dávka xxxxxxxxxxxxx xxxxxxx obsahuje:
Polysaccharidum Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx tetanico (xxxxxxxxx 25 xxxxxxxxxx).
1x)&xxxx;xxxxxxxx xxxxx proti xxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxx anatoxinum - min. 40 xxxxxxxxxxxxx jednotek
1e) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X v xxxxxx xxxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X - 10 xxxxxxxxxx
1x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B x xxxxxxx xxxxxxx
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
1x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím a xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(Xxxxxxx) xxx. 103,0&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1&xxxx;(XXX 4385) min. 103,7&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx virus xxxxxxxxxx2&xxxx;(Xxxxxx RA 27/3) xxx. 103,0&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
1 pomnoženo xx xxxxxxx xxxxxxxx xxxxxx
2&xxxx;xxxxxxxxx na xxxxxxxx xxxxxxxxxxx buňkách (XXX-5)
3&xxxx;50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
1xx)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx morbillorum1 vivum xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx xxx 1x103&xxxx;XXXX50*
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx X) xx xxxx xxx 12,5x103 CCID50*
Virus xxxxxxxx2&xxxx;xxxxx xxxxxxxxxx (kmen Xxxxxx XX 27/3) xx xxxx xxx 1x103&xxxx;XXXX50*
*&xxxx;50% infekční xxxxx xxxxxxx xxxxxxx
1&xxxx;xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx.
2&xxxx;xxxxxxxx xx lidských diploidních xxxxxxxx XX-38 fibroblastech.
1h) očkovací xxxxx xxxxx xxxxxx xxxxxxxx xxxxx v xxxxxxxxxxxx xxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Mahoney) ..... 40 antigenních X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) .......... 8 xxxxxxxxxxx X jednotek*
Virus xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) ........ 32 xxxxxxxxxxx X xxxxxxxx*
*&xxxx;xxxx množství ekvivalentních xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx metody.
1ch) očkovací xxxxx proti xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxx xxxxxxxx:
1xxx)&xxxx;xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1x&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31&xxxx;2,2 μg
Streptococci xxxxxxxxxx polysaecharidum xxxxxxxxx 41&xxxx;2,2 μg
Streptococci pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 μx
Xxxxxxxxxxxx pneumoniae polysaecharidum xxxxxxxxx 6X1&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1&xxxx;4,4 μg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X1&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V1 2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 141&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18X1&xxxx;2,2 μx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 19X1&xxxx;2,2 μg
Streptococci xxxxxxxxxx polysaecharidum xxxxxxxxx 19X1&xxxx;2,2 μx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X1&xxxx;2,2 μx
1 Konjugován x xxxxxx proteinem CRM197 x adsorbován xx xxxxxxxxxxx xxxxxxx (0,125 xx xxxxxxx).
X
1xxx)&xxxx;xxxxx pneumokokovým xxxxxxxx
xx 25 mikrogramech xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx sérotypů: 1, 2, 3, 4, 5, 6X, 7F, 8, 9N, 9V, 10X, 11A, 12F, 14, 15X, 17X, 18X, 19F, 19X, 20, 22F, 23X, 33X.
XXXX
1xxx)&xxxx;xxxxxxxxxxx xxxxxxxx xxxxx xxxxx pneumokokovým xxxxxxxx
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypů 1&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 3&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 4 1,2 2,2 μx
xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 5&xxxx;1,2&xxxx;2,2 μg
polysacharid xxxxxxxx (xxxxxxxxxx) Streptococcus pneumoniae xxxxxxxx 6A 1,2 2,2 μx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx xxxxxxxx 6B 1,2 4,4 μx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 7X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 8 1,2 2,2 μg
polysacharid xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 9X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 10X&xxxx;1,2&xxxx;2,2 μg
polysacharid bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 11X&xxxx;1,2&xxxx;2,2 μg
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 12X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 14&xxxx;1,2&xxxx;2,2 μg
polysacharid bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 15X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 18X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19F 1,2 2,2 μg
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 22F 1,2 2,2 μx
xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 23X&xxxx;1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 33X&xxxx;1,2&xxxx;2,2 μx
1 Xxxxxxxxxx x nosným xxxxxxxxx XXX197&xxxx;(xxxxxxxxx 51 μx xx dávku)
2 Xxxxxxxxxx na fosforečnan xxxxxxx (0,125 mg xxxxxxx na xxxxx)
1x)&xxxx;xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 - xx xxxx než 2 mezinárodní xxxxxxxx (XX) (2,5 Lf)
Tetani xxxxxxxxxx1&xxxx;- ne méně xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1-&xxxx;8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1&xxxx;- 8 xxxxxxxxxx
Xxxxxxxxx1&xxxx;2,5 xxxxxxxxxx
Xxxxx poliomyelitidis xxxxxxxxxxx:
xx xxx 1 (kmen Xxxxxxx)2&xxxx;- 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)2 - 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Saukett)2 - 32 X xxxxxxxx xxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx hydroxid xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Xx3+&xxxx;x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
2 pomnoženo xx XXXX xxxxxxx
XXXX
1xx)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx minimálně 2 IU* (2,5 Xx)
Xxxxxx anatoxinum minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 mikrogramů
Pertussis xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)**
xxxxx 1 40 X jednotek xxxxxxxx
xx xxx 2 8 X xxxxxxxx xxxxxxxx
xxxxx 3 32 D xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx hlinitý 1,5 xx (0,33 xx xxxxxxx)
*&xxxx;Xxxx xxxxxx xxxxxxx xxxxxxxxx spolehlivosti (p = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
**&xxxx;Xxxxxxxxxxx xx Xxxx xxxxxxx.
1x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (XXX vakcína)
1k) očkovací xxxxx proti virové xxxxxxxxxx B xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx xxxxx (0,5 xx) vakcíny xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X1,2,3&xxxx;- 20 xxxxxxxxxx
1 xxxxxxxxxx xx XX04X xxxxxxxxxx: - 3-X-xxxxxx-4'-xxxxxxxxxxxx-xxxxx X (XXX)2&xxxx;50 xxxxxxxxxx
2 xxxxxxxxxxx na fosforečnan xxxxxxx (xxxxxx 0,5 xxxxxxxxx Al3+)
3 vyrobeno xx xxxxxxx xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx cerevisiae) xxxxxxxxxxxxx XXX xxxxxxxxxxx.
2.&xxxx;Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxx xxxxxxxx
2x)&xxxx;xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx pro xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
2x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxxxx
2x)&xxxx;xxxxxxxx xxxxx xxxxx virové hepatitidě X xx xxxxxxx xxx dospělé:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxx X virus xxxxxxxxxxx
2x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(Xxxxxxx) xxx. 103,0&xxxx;xxxxxxxx dávka pro xxxxxxxx kulturu503
Parotitidis xxxxx xxxxxxxxxx1&xxxx;(XXX 4385) min. 103,7&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2&xxxx;(Xxxxxx XX 27/3) xxx. 103,0 infekční dávka xxx buněčnou kulturu503
1 pomnoženo xx buňkách kuřecích xxxxxx
2&xxxx;xxxxxxxxx na lidských xxxxxxxxxxx xxxxxxx (MRC-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
2xx)&xxxx;xxxxxxxx látka xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx než 1x103&xxxx;XXXX50*
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx X) ne xxxx xxx 12,5x103&xxxx;XXXX50*
Xxxxx xxxxxxxx2&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx méně než 1x103&xxxx;XXXX50*
*&xxxx;50% xxxxxxxx xxxxx xxxxxxx kultury
1 vyrobeno na xxxxxxx kuřecích xxxxxx.
2&xxxx;xxxxxxxx xx lidských xxxxxxxxxxx xxxxxxxx WI-38 fibroblastech.
3. Antigenní xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxx xxxxxxxx
3x)&xxxx;xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxxxxxx X inactivatum
3b) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx pro xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x)&xxxx;xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(Xxxxxxx) xxx. 103,0&xxxx;xxxxxxxx xxxxx pro buněčnou xxxxxxx503
Xxxxxxxxxxx xxxxx attenuatum1 (RIT 4385) xxx. 103,7&xxxx;xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
Xxxxxxxx virus attenuatum2 (Wistar XX 27/3) xxx. 103,0&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1&xxxx;xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2&xxxx;xxxxxxxxx xx xxxxxxxx diploidních xxxxxxx (XXX-5)
3&xxxx;50% infekční xxxxx xxxxxxx kultury
NEBO
3ca) očkovací xxxxx proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx attenuatum (xxxx Xxxxxx’ Xxxxxxxxx) xx xxxx než 1x103&xxxx;XXXX50*
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxx Lynn™, xxxxxxx X) xx xxxx xxx 12,5x103&xxxx;XXXX50*
Xxxxx xxxxxxxx2&xxxx;xxxxx xxxxxxxxxx (xxxx Wistar XX 27/3) ne xxxx než 1x1 103&xxxx;XXXX50*
*&xxxx;50% infekční xxxxx xxxxxxx xxxxxxx
1&xxxx;xxxxxxxx na xxxxxxx xxxxxxxx xxxxxx.
2&xxxx;xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Válek, XXx, XXX, XXXX, v. x.
Informace
Právní xxxxxxx č. 420/2023 Xx. xxxxx xxxxxxxxx xxxx 29.12.2023.
Ke xxx uzávěrky právní xxxxxxx xxxxx xxxxx xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.